Drawing for THERADAPTIVE

USPTO serial 90364548

THERADAPTIVE

Reviewed by CopyMark Law Group

Reg. 7732220Status 700Registered
Filing date
Status date
Registration date
Mar 18, 2025
Examiner
FRUM MILONE, MARCIE R
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with THERADAPTIVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ava R. Miller

Ava R. Miller WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304United States

Goods and services

ClassDescriptionStatusFirst use
005therapeutic proteins for medical use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, and chemotherapeutics; pharmaceutical and medicinal preparations and substances, namely, therapeutic proteins used for vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, and chemotherapeuticsACTIVEApr 11, 2024
042research and development in connection with protein therapies for use in pharmaceutical products; medical research and product development in the fields of biotechnology, drug discovery, pharmaceuticals, scientific research, and protein therapeutics; development of therapeutics, namely, pharmaceutical and medical therapies for use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, and chemotherapeutics; scientific research and developmentACTIVESep 11, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 25, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 25, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 25, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 25, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 13, 2024IUAFUSE AMENDMENT FILED—
Dec 13, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 6, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 6, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 6, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 13, 2024EX5GSOU EXTENSION 5 GRANTED—
Jun 13, 2024EXT5SOU EXTENSION 5 FILED—
Jun 13, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 13, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 11, 2023EX4GSOU EXTENSION 4 GRANTED—
Dec 11, 2023EXT4SOU EXTENSION 4 FILED—
Dec 11, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 11, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 9, 2023EX3GSOU EXTENSION 3 GRANTED—
May 9, 2023EXT3SOU EXTENSION 3 FILED—
May 9, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 14, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 12, 2022EX2GSOU EXTENSION 2 GRANTED—
Dec 12, 2022EXT2SOU EXTENSION 2 FILED—
Dec 12, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 11, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 9, 2022EX1GSOU EXTENSION 1 GRANTED—
Jun 9, 2022EXT1SOU EXTENSION 1 FILED—
Jun 9, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 14, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 19, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 19, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 29, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 15, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 15, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Sep 15, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 15, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 15, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
May 25, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 25, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 25, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 25, 2021DOCKASSIGNED TO EXAMINER—
Feb 12, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 10, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance